Successful treatment of Staphylococcus epidermidis hip prosthesis infection with oral linezolid

Annals of Pharmacotherapy

Volumn 38, Issue 6, 2004, Pages 986-988

  Mogenet, Ingrid ^a,b   Raetz Dillon, Sabine ^a   Canonge, Jean Marie ^a   Archambaud, Maryse ^a   Bonnet, Eric ^a  

^a CHU RANGUEIL   (France)

^b Appartement 6A ^*  (France)

Author keywords

Hip prosthesis infection; Linezolid; Multidrug resistant Staphylococcus epidermidis

Indexed keywords

LINEZOLID; METICILLIN;

ADULT; ARTICLE; CASE REPORT; DIARRHEA; DISEASE MARKER; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; GRAM POSITIVE BACTERIUM; HEADACHE; HIP ARTHROPLASTY; HIP PROSTHESIS; HUMAN; INFLAMMATION; METHICILLIN RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; MULTIDRUG RESISTANCE; NAUSEA; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROSTHESIS INFECTION; RASH; SIDE EFFECT; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ACETAMIDES; ANTI-BACTERIAL AGENTS; FEMALE; HIP PROSTHESIS; HUMANS; METHICILLIN RESISTANCE; MIDDLE AGED; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 2442688352     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D354     Document Type: Article

References (15)

1. Hanssen AD, Rand JA. An instructional course lecture. The American Academy of Orthopaedic Surgeons. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. J Bone Joint Surg Am 1998;80:910-22.
2. Brause BD. Infections with prostheses in bones and joints. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000:1196-200.
3. Mader JT, Wang J, Calhoun JH. Antibiotic therapy for musculoskeletal infections. J Bone Joint Surg Am 2001;83:1878-90.
4. Jacqueline C, Batard E, Perez L, Boutoille D, Hamel A, Caillon J, et al. In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model. Antimicrob Agents Chemother 2002;46:3706-11.
5. Rybak MJ, Cappelletty DM, Moldovan T, Aeschlimann JR, Kaatz GW. Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium. Antimicrob Agents Chemother 1998;42:721-4.
6. Package insert. Zyvoxid (linezolid). Kalamazoo, MI: Pharmacia and Upjohn, 2001.
7. Patel R, Piper KE, Rouse MS, Steckelberg JM. Linezolid therapy of Staphylococcus aureus experimental osteomyelitis. Antimicrob Agents Chemother 2000;44:3438-40.
8. Melzer M, Goldsmith D, Gransden W. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias. Clin Infect Dis 2000;31:208-9.
9. Moise PA, Forrest A, Birmingham MC, Schentag JJ. The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin. J Antimicrob Chemother 2002;50:1017-26.
10. Bassetti M, Di Biagio A, Cenderello G, Del Bono V, Palermo A, Cruciani M, et al. Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA). J Infect 2001;43:148-9.
11. Lovering AM, Zhang J, Bannister GC, Lankester BJ, Brown JG, Narendra G, et al. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother 2002;50:73-7.
12. Betriu C, Redondo M, Boloix A, Gomez M, Culebras E, Picazo JJ. Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci. J Antimicrob Chemother 2001;48:911-3.
13. Cercenado E, Garcia-Garote F, Bouza E. In vitro activity of linezolid against multiply resistant gram-positive clinical isolates. J Antimicrob Chemother 2001;47:77-81.
14. Antony SJ, Diaz-Vasquez E, Stratton C. Clinical experience with linezolid in the treatment of resistant gram-positive infections. J Natl Med Assoc 2001;93:386-91.
15. Jover-Saenz A, Gaite FB, Ribelles AG, Porcel-Perez JM, Garrido-Calvo S. Linezolid treatment of total prosthetic knee infection due to methicillin-resistant Staphylococcus epidermidis. J Infect 2003;47:87-8.